Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-006649

See Remarks acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Tony W See Remarks 2019-03-05 Grant or award +10,000 $40.87 $408,700 32,869 D
Derivatives
Ho Tony W See Remarks 2019-03-05 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…